Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population

Jaroslav A. Hubáček(Institute of Clinical and Experimental Medicine), Jan Piťha(Institute of Clinical and Experimental Medicine), R. Poledne(Institute of Clinical and Experimental Medicine), M Gebauerová(Institute of Clinical and Experimental Medicine), Jana Matoušková(General University Hospital in Prague), Martin Pěnička, Hana Skalická(Unknown), Hana Hrabáková(University Hospital Kralovske Vinohrady), Josef Veselka(Baim Institute for Clinical Research), V Lánská(Institute of Clinical and Experimental Medicine), V. Staněk(Institute of Clinical and Experimental Medicine), V Adámková(University of South Bohemia in České Budějovice), Michael Aschermann, A. Krüger(Na Homolce Hospital), Petr Hájek(University Hospital in Motol)
Folia Biologica
January 1, 2012
10.14712/fb2012058050203
Cited by 12

Related Papers

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|709
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
|BMJ|2014|677
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2017|348
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2018|336